Message-ID: <11648454.1075840989939.JavaMail.evans@thyme>
Date: Wed, 16 Jan 2002 12:16:12 -0800 (PST)
From: investfacts@utarget.sparklist.com
To: alewis@ect.enron.com
Subject: Free Package on BioTech Stock in Red-Hot Market
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-From: "InvestFacts" <InvestFacts@utarget.sparklist.com>@ENRON
X-To: alewis@ect.enron.com
X-cc: 
X-bcc: 
X-Folder: \ExMerge - Lewis, Andrew H.\Deleted Items
X-Origin: LEWIS-A
X-FileName: andy lewis 6-25-02.PST

Click here now  to receive your FREE investor care package 
on a New BioTech Stock in a Red-Hot Market! 
Centrex Inc. (CNEX - OTCBB) 
Centrex Inc. (CNEX - OTCBB) owns the exclusive rights  
to a bacteria-detection system developed at Los Alamos  
National Laboratory which allows for the detection of E. Coli. 
The company believes its proprietary technology can also be used 
for the detection of other bacterial and viral agents. 
Investment Highlights on Centrex Inc. (CNEX - OTCBB) 
New bioTech stock in red-hot market 
Company to market detection technology to 
- Postal Service 
- Military 
- State and City Health Departments 
- Airports 
Research contract with Los Alamos National Laboratory 
Technology is adaptable to detect a variety of organisms  
Grant application received from the federal government 
Other viral and bacterial agents being looked at for detection include 
- Salmonella typhi (typhoid) 
- Vibrio cholerae (cholera) 
- Yersinia pestis (plague) 
- Ebola 
Click here now  to receive your FREE investor care package 
on a New BioTech Stock in a Red-Hot Market! 
Centrex Inc. (CNEX - OTCBB) 
  
  
  
Disclaimer: InvestFacts.com was paid $5,000 US by Corporate Profile
of NY for this distribution. InvestFacts.com does not own stock in 
Centrex Inc. and is not affiliated with Centrex Inc.. The words and 
claims contained in this report are those of Corporate Profile of New York 
and not Investfacts.com. Investfacts.com has not attempted to verify 
any of the claims or statements contained herein. Investors must conduct 
their own due diligence. This notice shall not constitute an offer to sell 
or the solicitation of an offer to buy nor shall there be any sale of these 
securities in any state in which such offer, solicitation or sale would be 
unlawful prior to registration or qualification under the securities laws of 
any such state. Please check with your broker or with the company to determine 
whether these securities may be purchased or sold in your state of residence prior 
to effecting a transaction. The statements contained herein that are not statements 
of historical fact, including statements related to future financial expectations or 
industry growth expectations are "forward-looking statements" and involve risk and 
uncertainty. Actual results may differ due to numerous factors. See the company's 
filings with the Securities and Exchange Commission for details on such factors. 
  
  --- You are currently subscribed to investfacts as: alewis@ect.enron.com To unsubscribe send a blank email to leave-investfacts-40195N@utarget.sparklist.com